AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17018651 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human GH (rhGH) treatment
Number of subjects: 61
Study 17018651 — intervention group
Group type: COMPARATOR
Intervention: no treatment
Number of subjects: 61
Study 14615476 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine 50 mg/day for 14 days
Number of subjects: 12
Study 14615476 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 14615476 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine 50 mg/day
Number of subjects: 12
Study 11033986 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanuts (2092 kJ / 500 kcal)
Number of subjects: 24
Study 11033986 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanut butter (rheology control, 2092 kJ / 500 kcal)
Number of subjects: 24
Study 11033986 — intervention group
Group type: EXPERIMENTAL
Intervention: Almonds (2092 kJ / 500 kcal)
Number of subjects: 24
Study 11033986 — intervention group
Group type: EXPERIMENTAL
Intervention: Chestnuts (macronutrient control, 2092 kJ / 500 kcal)
Number of subjects: 24
Study 11033986 — intervention group
Group type: EXPERIMENTAL
Intervention: Chocolate (sensory control, 2092 kJ / 500 kcal)
Number of subjects: 24
Study 11033986 — intervention group
Group type: COMPARATOR
Intervention: Low energy preloads
Number of subjects: 24
Study 11033986 — intervention group
Group type: COMPARATOR
Intervention: No preload (time control)
Number of subjects: 24
Study 9179279 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose Ara-C (HDAC) combined with high dose mitoxantrone
Number of subjects: 0
Study 9179279 — intervention group
Group type: COMPARATOR
Intervention: Standard vincristine, prednisone, anthracycline-based regimen
Number of subjects: 0
Study 7678711 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (0.3 microgram/kg bodyweight)
Number of subjects: 16
Study 7678711 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin
Number of subjects: 16
Study 7678711 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of dextran 70 and desmopressin
Number of subjects: 16
Study 7678711 — intervention group
Group type: COMPARATOR
Intervention: Control (no desmopressin)
Number of subjects: 16
Study 3468776 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary restraint
Number of subjects: 97
Study 3468776 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of previous binge eating and coexistence of high levels of depression and dietary restraint
Number of subjects: 97
Study 3468776 — intervention group
Group type: EXPERIMENTAL
Intervention: Binge eating
Number of subjects: 97
Study 30075760 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 59
Study 30075760 — intervention group
Group type: COMPARATOR
Intervention: Nilotinib
Number of subjects: 59
Study 30075760 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib or Nilotinib (optimal response at 12 months)
Number of subjects: 59
Study 30075760 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib or Nilotinib (optimal response at 6 months)
Number of subjects: 59
Study 30075760 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib or Nilotinib (optimal response at 3 months)
Number of subjects: 59
Study 30075760 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib or Nilotinib (optimal response at 3, 6, or 12 months)
Number of subjects: 59
Study 30075760 — intervention group
Group type: COMPARATOR
Intervention: Nilotinib vs Imatinib
Number of subjects: 59
Study 27554197 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 57
Study 27554197 — intervention group
Group type: COMPARATOR
Intervention: Non Directive Reflective Listening (NDRL)
Number of subjects: 57
Study 24832978 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling with power output alternating between 50 and 100 W every 5 minutes (P2)
Number of subjects: 30
Study 24832978 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling with power output alternating between 25 and 125 W every 5 minutes (P3)
Number of subjects: 30
Study 21958662 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction Osteogenesis (DO)
Number of subjects: 39
Study 21958662 — intervention group
Group type: COMPARATOR
Intervention: Conventional Orthognathic Surgery (CO)
Number of subjects: 39
Study 20039972 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric bypass surgery after lifestyle modifications
Number of subjects: 20
Study 20039972 — intervention group
Group type: COMPARATOR
Intervention: Weekly follow-up (Control group)
Number of subjects: 20
Study 18555912 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbocisteine (1500 mg per day for 1 year)
Number of subjects: 709
Study 18555912 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 709
Study 16162626 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C with L-arginine
Number of subjects: 28
Study 16162626 — intervention group
Group type: COMPARATOR
Intervention: Intravenous normal saline with L-arginine
Number of subjects: 28
Study 16162626 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C alone
Number of subjects: 28
Study 11795726 — intervention group
Group type: COMPARATOR
Intervention: Healthy older adults (n = 17)
Number of subjects: 17
Study 11795726 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with lumbar nerve root compression
Number of subjects: 17
Study 10422631 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg elemental iron with folic acid (0.5 mg) per day for 12 weeks
Number of subjects: 3
Study 10422631 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg elemental iron with folic acid (0.5 mg) per day for 12 weeks
Number of subjects: 3
Study 10422631 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 mg elemental iron with folic acid (0.5 mg) per day for 12 weeks
Number of subjects: 3
Study 7593683 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 30
Study 7593683 — intervention group
Group type: COMPARATOR
Intervention: Nondirective supportive therapy
Number of subjects: 30
Study 2209307 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer algorithms for insulin dosage adjustment
Number of subjects: 0
Study 2209307 — intervention group
Group type: COMPARATOR
Intervention: Manual methods for insulin dosage adjustment
Number of subjects: 0
Study 2209307 — intervention group
Group type: EXPERIMENTAL
Intervention: Microprocessor device for insulin dosage adjustment
Number of subjects: 0
Study 2209307 — intervention group
Group type: COMPARATOR
Intervention: Control group (manual methods)
Number of subjects: 0
Study 6993113 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal methotrexate
Number of subjects: 29
Study 6993113 — intervention group
Group type: COMPARATOR
Intervention: Intravenous cyclophosphamide
Number of subjects: 29
Study 31142350 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation Enabling Care in Nursing (PECAN) intervention
Number of subjects: 578
Study 31142350 — intervention group
Group type: COMPARATOR
Intervention: Optimised standard care (usual care and an information session)
Number of subjects: 578
Study 31142350 — intervention group
Group type: EXPERIMENTAL
Intervention: PECAN intervention
Number of subjects: 578
Study 28523932 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated testing intervention
Number of subjects: 84
Study 28523932 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 84
Study 24994769 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation according to the American Society of Shoulder and Elbow Therapists' rehabilitation guideline
Number of subjects: 96
Study 24994769 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 96
Study 23512711 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-glycemic diet (LoGIX)
Number of subjects: 20
Study 23512711 — intervention group
Group type: COMPARATOR
Intervention: High-glycemic diet (HiGIX)
Number of subjects: 20
Study 21372744 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 121
Study 21372744 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 121
Study 19118956 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention group (DG) receiving approximately 1200 mg of calcium and 7.5 microg of vitamin D3 per day via fortified dairy products and attending biweekly dietary and lifestyle intervention sessions
Number of subjects: 101
Study 19118956 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention group (DG)
Number of subjects: 101
Study 19118956 — intervention group
Group type: COMPARATOR
Intervention: Calcium supplemented group (CaG) receiving a total of 1200 mg calcium per day
Number of subjects: 101
Study 19118956 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) who continued with their usual diet
Number of subjects: 101
Study 17360900 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo) 40,000 IU
Number of subjects: 23
Study 17360900 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 23
Study 15122940 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-adolescent disagreement regarding behavioral and emotional problems
Number of subjects: 0
Study 15122940 — intervention group
Group type: EXPERIMENTAL
Intervention: Child Behavior Checklist (CBCL) and Youth Self-Report (YSR) assessments
Number of subjects: 0
Study 11409827 — intervention group
Group type: EXPERIMENTAL
Intervention: Lycra garments (Kendall‐Camp UK Ltd) worn for at least 6 hours a day for 6 weeks
Number of subjects: 12
Study 9403142 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective processing tasks (colour-naming interference and interpretation of ambiguous situations)
Number of subjects: 48
Study 9403142 — intervention group
Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 48
Study 8322058 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste containing sodium fluoride
Number of subjects: 6
Study 8322058 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste containing amine fluoride
Number of subjects: 6
Study 8322058 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste containing sodium monofluorophosphate
Number of subjects: 6
Study 3618443 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen (open study in 14 asthmatics)
Number of subjects: 24
Study 3618443 — intervention group
Group type: COMPARATOR
Intervention: Initial oral provocation tests (OPT)
Number of subjects: 24
Study 31409486 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy + Bevacizumab (BEV)
Number of subjects: 1538
Study 31409486 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy + Placebo (P)
Number of subjects: 1538
Study 31409486 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups (BEV and placebo)
Number of subjects: 1538
Study 31409486 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall analysis of adiposity measures
Number of subjects: 1538
Study 28103752 — intervention group
Group type: EXPERIMENTAL
Intervention: MynxGrip vascular closure device (VCD)
Number of subjects: 66
Study 25560100 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustable single-incision sling
Number of subjects: 156
Study 25560100 — intervention group
Group type: COMPARATOR
Intervention: Transobturator sling
Number of subjects: 156
Study 23025500 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive stereotype exposure (e.g., 'Asians are good at math', 'women are nurturing')
Number of subjects: 5
Study 23025500 — intervention group
Group type: COMPARATOR
Intervention: No stereotype exposure
Number of subjects: 5
Study 23025500 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent self-construal
Number of subjects: 5
Study 23025500 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdependent self-construal
Number of subjects: 5
Study 21319896 — intervention group
Group type: EXPERIMENTAL
Intervention: ModerateDrinking.com (MD) combined with Moderation Management (MM)
Number of subjects: 80
Study 21319896 — intervention group
Group type: COMPARATOR
Intervention: Moderation Management (MM) alone
Number of subjects: 80
Study 19842825 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief motivational intervention (BMI) for resolution of ambivalence and sex risk reduction planning
Number of subjects: 0
Study 19842825 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI with biological feedback based on testing for STIs
Number of subjects: 0
Study 19842825 — intervention group
Group type: COMPARATOR
Intervention: Nonintervention control (standard HIV information dissemination)
Number of subjects: 0
Study 16904542 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT) with AVJ ablation
Number of subjects: 48
Study 16904542 — intervention group
Group type: COMPARATOR
Intervention: Cardiac resynchronization therapy (CRT) without AVJ ablation
Number of subjects: 48
Study 16904542 — intervention group
Group type: COMPARATOR
Intervention: Cardiac resynchronization therapy (CRT) in sinus rhythm (SR) patients
Number of subjects: 48
Study 15005820 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 10
Study 15005820 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 11175677 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed Movement Battery (TMB) at self‐selected speeds
Number of subjects: 30
Study 11175677 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed Movement Battery (TMB) at maximum‐movement speeds
Number of subjects: 30
Study 11175677 — intervention group
Group type: COMPARATOR
Intervention: Criterion tests (Berg Balance Scale, Timed 'Up & Go' Test, Barthel Index, and 18‐item ADL/IADL scale)
Number of subjects: 30
Study 9753210 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 12
Study 9753210 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone
Number of subjects: 12
Study 9753210 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 12
Study 7801757 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooled saw blade
Number of subjects: 33
Study 7801757 — intervention group
Group type: COMPARATOR
Intervention: Conventional blade
Number of subjects: 33
Study 3140734 — intervention group
Group type: EXPERIMENTAL
Intervention: MMC and FT-207
Number of subjects: 54
Study 3140734 — intervention group
Group type: COMPARATOR
Intervention: MMC and UFT
Number of subjects: 54
Study 31017306 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhang's guideline
Number of subjects: 7277
Study 31017306 — intervention group
Group type: COMPARATOR
Intervention: WHO partograph
Number of subjects: 7277
Study 26114393 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine added to University of Wisconsin solution
Number of subjects: 115
Study 26114393 — intervention group
Group type: COMPARATOR
Intervention: Standard University of Wisconsin solution
Number of subjects: 115
Study 25174261 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 3.75%
Number of subjects: 42
Study 24194754 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal onlay BMG urethroplasty
Number of subjects: 40
Study 24194754 — intervention group
Group type: COMPARATOR
Intervention: Ventral BMG urethroplasty
Number of subjects: 40
Study 20734028 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (cycling at 75% of VO(2peak))
Number of subjects: 28
Study 20734028 — intervention group
Group type: EXPERIMENTAL
Intervention: Power exercise (leg press at 75% of one repetition maximum plus jumping sequence)
Number of subjects: 28
Study 19957874 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO trial (6.4% w/v glucose and maltodextrin solution)
Number of subjects: 7
Study 19957874 — intervention group
Group type: COMPARATOR
Intervention: PLA trial (placebo solution)
Number of subjects: 7
Study 16749411 — intervention group
Group type: EXPERIMENTAL
Intervention: Active pulsed electromagnetic therapy (PEMT)
Number of subjects: 36
Study 16749411 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 36
Study 15090561 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine (mean dosage 35.8 mg)
Number of subjects: 60
Study 15090561 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 15090561 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 60
Study 15090561 — intervention group
Group type: COMPARATOR
Intervention: Clozapine and Placebo
Number of subjects: 60
Study 11331953 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial review of 125 slides by 12 pathologists
Number of subjects: 250
Study 11331953 — intervention group
Group type: EXPERIMENTAL
Intervention: Second review of 125 slides by 12 pathologists
Number of subjects: 250
Study 11331953 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis using 4 diagnostic categories (BE; IND; LGD; HGD and carcinoma)
Number of subjects: 250
Study 11331953 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of interobserver agreement for HGD/carcinoma
Number of subjects: 250
Study 11331953 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of interobserver agreement for BE
Number of subjects: 250
Study 11331953 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of interobserver agreement for LGD
Number of subjects: 250
Study 11331953 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of interobserver agreement for IND
Number of subjects: 250
Study 9173967 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 9173967 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (4 mg)
Number of subjects: 15
Study 9173967 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (100 mg)
Number of subjects: 15
Study 9173967 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (1 mg) suppression test
Number of subjects: 15
Study 9173967 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine vasopressin (AVP) infusion
Number of subjects: 15
Study 9173967 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral characteristics
Number of subjects: 15
Study 7930246 — intervention group
Group type: EXPERIMENTAL
Intervention: Prourokinase (60 mg or 80 mg monotherapy or 60 mg primed with 250,000 IU recombinant urokinase)
Number of subjects: 128
Study 2856053 — intervention group
Group type: EXPERIMENTAL
Intervention: High potassium diet
Number of subjects: 0
Study 2856053 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium diet
Number of subjects: 0
Study 2856053 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium, high potassium diet
Number of subjects: 0
Study 2856053 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 31689482 — intervention group
Group type: EXPERIMENTAL
Intervention: Loxoprofen sodium (60 mg once orally)
Number of subjects: 229
Study 31689482 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 229
Study 31158346 — intervention group
Group type: EXPERIMENTAL
Intervention: Valerian 100 mg
Number of subjects: 20
Study 31158346 — intervention group
Group type: COMPARATOR
Intervention: Midazolam 15 mg
Number of subjects: 20
Study 28088498 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 400 mcg vaginally
Number of subjects: 140
Study 28088498 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 26634113 — intervention group
Group type: EXPERIMENTAL
Intervention: Water based extract of propolis mouth wash (15 ml, 3 times a day)
Number of subjects: 20
Study 26634113 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouth wash (15 ml)
Number of subjects: 20
Study 24279229 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated altitude of 25,000 ft (7620 m)
Number of subjects: 0
Study 24279229 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated altitude of 17,500 ft (5334 m)
Number of subjects: 0
Study 24279229 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 0
Study 20872023 — intervention group
Group type: EXPERIMENTAL
Intervention: Haptics-trained group
Number of subjects: 33
Study 20872023 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonhaptics-trained group
Number of subjects: 33
Study 20872023 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 33
Study 19092152 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfuzosin 10 mg per day for 12 weeks
Number of subjects: 272
Study 19092152 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 272
Study 22773108 — intervention group
Group type: EXPERIMENTAL
Intervention: Copeland RHHI
Number of subjects: 21
Study 22773108 — intervention group
Group type: EXPERIMENTAL
Intervention: Global C.A.P RHHI
Number of subjects: 21
Study 22773108 — intervention group
Group type: COMPARATOR
Intervention: Both RHHI groups
Number of subjects: 21
Study 15949728 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) at doses of 0.05, 0.2, and 0.5 microg/kg/min
Number of subjects: 19
Study 15949728 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitric oxide (NO) at doses of 40, 60, and 80 ppm
Number of subjects: 19
Study 12566659 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in peritoneal solute clearance
Number of subjects: 0
Study 12566659 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual renal function
Number of subjects: 0
Study 12566659 — intervention group
Group type: EXPERIMENTAL
Intervention: General findings
Number of subjects: 0
Study 10630057 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstetric analgesia by peridural way (Group I)
Number of subjects: 129
Study 10630057 — intervention group
Group type: COMPARATOR
Intervention: No analgesia (Group II)
Number of subjects: 129
Study 7995764 — intervention group
Group type: EXPERIMENTAL
Intervention: Conformal radiation treatment
Number of subjects: 409
Study 7995764 — intervention group
Group type: COMPARATOR
Intervention: Standard radiation treatment
Number of subjects: 409
Study 7995764 — intervention group
Group type: EXPERIMENTAL
Intervention: Conformal technique in patients 65 years or older
Number of subjects: 409
Study 7995764 — intervention group
Group type: COMPARATOR
Intervention: Standard technique in patients 65 years or older
Number of subjects: 409
Study 2186980 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg at 8 am
Number of subjects: 130
Study 2186980 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg at 10 pm
Number of subjects: 130
Study 2186980 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130